HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 86 filers reported holding HOMOLOGY MEDICINES INC in Q4 2019. The put-call ratio across all filers is 81.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,372 | +32.2% | 1,173 | 0.0% | 0.00% | – |
Q2 2023 | $1,038 | -99.4% | 1,173 | -97.9% | 0.00% | – |
Q1 2022 | $172,000 | -21.5% | 56,715 | -5.7% | 0.00% | – |
Q4 2021 | $219,000 | -53.6% | 60,141 | +0.2% | 0.00% | -100.0% |
Q3 2021 | $472,000 | +9.8% | 60,009 | +1.4% | 0.00% | 0.0% |
Q2 2021 | $430,000 | +22.5% | 59,167 | +58.7% | 0.00% | – |
Q1 2021 | $351,000 | -23.7% | 37,291 | -8.5% | 0.00% | -100.0% |
Q4 2020 | $460,000 | +13.3% | 40,746 | +7.5% | 0.00% | 0.0% |
Q3 2020 | $406,000 | -37.6% | 37,908 | -11.5% | 0.00% | 0.0% |
Q2 2020 | $651,000 | +44.3% | 42,854 | +47.6% | 0.00% | 0.0% |
Q1 2020 | $451,000 | -24.3% | 29,043 | +0.9% | 0.00% | 0.0% |
Q4 2019 | $596,000 | +15.5% | 28,785 | +1.0% | 0.00% | 0.0% |
Q3 2019 | $516,000 | -3.6% | 28,500 | +4.3% | 0.00% | 0.0% |
Q2 2019 | $535,000 | -7.8% | 27,322 | +30.7% | 0.00% | 0.0% |
Q1 2019 | $580,000 | +22.1% | 20,898 | -1.7% | 0.00% | 0.0% |
Q4 2018 | $475,000 | +131.7% | 21,260 | +137.1% | 0.00% | – |
Q3 2018 | $205,000 | – | 8,966 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 4,535,919 | $51,211,000 | 17.25% |
Vida Ventures Advisors, LLC | 770,845 | $8,703,000 | 1.79% |
AAF Wealth Management, LLC | 59,790 | $675,000 | 0.61% |
Vivo Capital, LLC | 853,143 | $9,632,000 | 0.43% |
Bellevue Group AG | 1,737,122 | $19,612,000 | 0.22% |
PREMIER ASSET MANAGEMENT LLC | 77,108 | $871,000 | 0.18% |
Temasek Holdings (Private) Ltd | 3,220,293 | $36,357,000 | 0.16% |
American Investment Services, Inc. | 36,955 | $417,000 | 0.13% |
Virtus ETF Advisers LLC | 24,646 | $278,000 | 0.12% |
FIRST MIDWEST BANK TRUST DIVISION | 65,983 | $745,000 | 0.11% |